Africa Cancer Leaders Institute

非洲癌症领袖研究所

• 批准号: 9567967
• 负责人: OLUFUNMILAYO F. OLOPADE
• 金额: $ 3万
• 依托单位: UNIVERSITY OF CHICAGO
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-20 至 2022-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9567967
• 关键词: Address; Advocacy; Africa; African; Area; Award; Cancer Research Project; Career Mobility; Clinical; Clinical Research; Collaborations; Country; Development; Development Plans; Electronic Medical Records and Genomics Network; Epidemic; Evaluation; Faculty; Fostering; Funding; Generations; Goals; Grant; Income; Individual; Institutes; Knowledge; Leadership; Learning; Location; Malignant Neoplasms; Mentors; Mentorship; Minority; Participant; Publications; Publishing; Records; Research; Research Personnel; Rwanda; Scholarship; Series; Training; Travel; Woman; anticancer research; cancer care; cancer therapy; career; career development; clinical development; cohort; design; education research; experience; improved; innovation; leadership development; lectures; meetings; member; outreach; patient oriented; peer; programs; public-private partnership; research and development; symposium

SUMMARY The proposed African Cancer Leaders Institute (ACLI) is a “meeting within a meeting” designed to coincide with the biennial AORTIC conference, beginning with the forthcoming, “Cancer in Africa: Making Strides, Creating Solutions” in Kigali, Rwanda, November 7-10, 2017. The ACLI will identify young clinical research leaders who are capable of leading interdisciplinary teams to improve cancer treatment in Africa. The long-term goal of the ACLI is to provide an intellectually stimulating platform to propel emerging global cancer leaders from Africa and the US to receive support for innovative cancer research in Africa, and to stimulate an African network for emerging leaders in cancer research in Africa. The ACLI platform will have annual goals and objectives set by the Education and Research Sub-Committees of AORTIC in collaboration with the ACLI program Organizers. The ACLI will widely solicit competitive applications from the US and Africa. Five emerging Leaders will be fully-funded for travel and participation in ACLI and the AORTIC conference. Five emerging Leaders from high-income countries with meritorious abstracts and application will be selected for Merit travel award in order to forge professional relationships and foster peer mentorship. Participants will attend lectures on best practices in developing a research career, identifying and developing cancer research projects, and disseminating research to a variety of audiences. Special sessions will be arranged for ACLI participants to discuss and evaluate the concepts presented at the AORTIC conference to enhance participants' learning and career development experience. All participants will have a chance to be mentored by Senior Leaders attending the main conference. Each ACLI participant will be asked to prepare a brief 15 minute overview of career accomplishments and plans for their career development activities as an emerging leader for cancer research in Africa. We will track a number of metrics including conference evaluations, career landmarks, publication records and the number of ACLI members who compete successfully for Africa focused K43 and K07 or K23 grants.

总结 拟议中的非洲癌症领导人研究所是一个“会议中的会议”， 随着两年一度的AORTIC会议，从即将举行的“非洲癌症：大步前进， 2017年11月7日至10日在卢旺达基加利举行的“创造解决方案”。ACLI将确定年轻的临床研究 有能力领导跨学科团队改善非洲癌症治疗的领导者。长期 ACLI的目标是提供一个智力激励平台，以推动新兴的全球癌症领导者 从非洲和美国获得对非洲创新癌症研究的支持， 非洲癌症研究新兴领导者网络。ACLI平台将有年度目标， 由AORTIC的教育和研究小组委员会与ACLI合作制定的目标 节目组织者。ACLI将广泛征求来自美国和非洲的竞争性申请。五 新兴领导人将获得全额资助，用于旅行和参加ACLI和AORTIC会议。 来自高收入国家的五位具有杰出摘要和应用程序的新兴领导人将被 被选为优秀旅行奖，以建立专业关系和促进同行指导。 参与者将参加有关发展研究事业，确定和发展 癌症研究项目，并向各种受众传播研究成果。特别会议将在 安排ACLI参与者讨论和评估在AORTIC会议上提出的概念， 加强学员的学习和职业发展经验。所有参与者将有机会 由出席主要会议的高级领导人指导。每个ACLI参与者将被要求准备一份 简要介绍15分钟的职业成就和职业发展活动计划， 非洲癌症研究的新兴领导者。我们将跟踪一些指标，包括会议 评估、职业里程碑、出版记录和参加竞争的ACLI成员数量 成功获得以非洲为重点的K43和K07或K23赠款。